Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

Silicon Lab-on-a-chip Test Could Provide Cheaper, Portable Diagnostics

by Global Biodefense Staff December 2, 2020, 8:22 am
Far Too Few Rapid COVID-19 Tests Available in U.S. to Put a Dent in the Pandemic

by Bonnie LaFleur and Katherine Ellingson December 1, 2020, 12:17 pm
InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics

by Global Biodefense Staff October 31, 2020, 11:27 am
DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

by Global Biodefense Staff October 22, 2020, 5:38 pm
Big Ideas: Rapidly Detecting Single Molecules with a Tiny Circular Light Racetrack

by Judith Su October 22, 2020, 8:20 am
Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher

by Global Biodefense Staff October 20, 2020, 2:34 pm
Finding the Golden Window for Collecting COVID-19 Survivor Antibodies

by Global Biodefense Staff October 19, 2020, 4:26 pm
Is Your Infection Bacterial or Viral? DoD-Backed Screening Device Gives Quick Answers

by Global Biodefense Staff October 19, 2020, 3:16 pm
DoD Researchers Collaborate on Universal Antibody Test for COVID-19

by Global Biodefense Staff October 15, 2020, 1:12 pm
MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2

by Global Biodefense Staff October 15, 2020, 10:46 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal

by Global Biodefense Staff October 15, 2020, 5:04 am
UCLA Scientists Pioneer SwabSeq Rapid COVID-19 Diagnostic

by Global Biodefense Staff October 13, 2020, 6:04 pm
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV

by Global Biodefense Staff October 8, 2020, 11:28 am
Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection

by Global Biodefense Staff October 8, 2020, 7:36 am

Congratulations. You've reached the end of the internet.

Biodetection

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Researchers Adapt Cell Phone Camera for SARS-CoV-2 Detection

Silicon Lab-on-a-chip Test Could Provide Cheaper, Portable Diagnostics

Far Too Few Rapid COVID-19 Tests Available in U.S. to Put a Dent in the Pandemic

InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics

DoD Leverages Lung-on-a-Chip Technology for COVID-19 Research

Big Ideas: Rapidly Detecting Single Molecules with a Tiny Circular Light Racetrack

Centivax Licenses Anti-COVID-19 Antibodies to Thermo Fisher

Finding the Golden Window for Collecting COVID-19 Survivor Antibodies

Is Your Infection Bacterial or Viral? DoD-Backed Screening Device Gives Quick Answers

DoD Researchers Collaborate on Universal Antibody Test for COVID-19

MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2

DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal

UCLA Scientists Pioneer SwabSeq Rapid COVID-19 Diagnostic

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV

Harvard Wyss Institute Licenses Diagnostic Technologies to Agile Biodetection

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest Articles

More Biodetection News